A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Beijing Boren Hospital
University of Nebraska
SecuraBio
University of California, San Francisco
Medigene AG
CTI BioPharma
Bellicum Pharmaceuticals
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ann & Robert H Lurie Children's Hospital of Chicago
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Hamad Medical Corporation
AbbVie
University of Alabama at Birmingham
Hoag Memorial Hospital Presbyterian
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Children's Oncology Group
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Duke University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Enzon Pharmaceuticals, Inc.
Case Comprehensive Cancer Center
Nevada Cancer Institute